Tag Archive for: Agomab

Photo credits: Markus Winkler
IPO

AgomAb files for U.S. IPO as fibrosis-focused pipeline moves deeper into the clinic

AgomAb Therapeutics has filed for an initial public offering (IPO) in the U.S., looking to tap public markets to fund the next stage of development for its pipeline in fibrotic and inflammatory diseases. The Antwerp-based biotech said in its filing with the U.S. Securities and Exchange Commission that it plans to list its shares on Nasdaq under the ticker AGMB.

Read more
Hepatocyte growth factor activator, a serine protease that activates hepatocyte growth factor.123rf.com/Iculig
Agomab

Agomab raises US$89m in Series D

Another strong financing round for Belgian Agomab NV. Sanofi is joining the band wagon of targeting the TGFbeta receptor.

Read more
© Gerd Altmann - pixabay
antibody

Agomab Therapeutics NV raises US$100m in Series C financing

Belgian fibrosis specialist Agomab Therapeutics NV has raised US$100m to advance development of its pipeline.

Read more